- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01668979
Assessment of a New System to Detect, Quantify and Treat Near Falls in Older Adults
August 16, 2012 updated by: Michal Roll PhD,MBA, Tel-Aviv Sourasky Medical Center
The study is aimed to assess a new system for the automatic detection, quantification and treatment of Near Fall (NF) episodes in healthy older adults with a history of falls.
The system is comprized of a treadmill and a virtual reality simulation which provides a motor-cognitive challenge to provoke NF.
The challenges provided by the system are individualized and using machine learning algorithms will enable the identification and detection of NF under different conditions and allow for the most suitable treatment.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
20
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Tel Aviv, Israel, 64239
- Tel Aviv Sourasky Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
60 years to 85 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Healthy older adults with a history of falls
Description
Inclusion Criteria:
- Healthy older adults with a history of falls or complaints of gait instability
- Able to walk independently for at least 10 minutes
Exclusion Criteria:
Systemic chronic or acute pathologies:
- Ischemic heart disease
- Orthopedic or Rheumatic diseases
- Severe vision problems
- Neurological disease: PD, AD, CVA
- Patients who underwent brain surgery in the last 6 months prior to the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
new system to detect Near Falls
the new system comprises of a treadmill and a virtual reality simulation that will be used to induce Near Falls in healthy older adults with a history of falls.
|
We will invite healthy older adults with a history of falls to try the new system and assess whether the new system can induce, detect and quantify Near Fall episodes
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
usability of the system to detect Near Falls
Time Frame: one year
|
one year
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Near Fall severity
Time Frame: one year
|
one year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Nir Giladi, MD, Tel-Aviv Sourasky Medical Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2012
Primary Completion (Anticipated)
September 1, 2013
Study Completion (Anticipated)
September 1, 2013
Study Registration Dates
First Submitted
August 16, 2012
First Submitted That Met QC Criteria
August 16, 2012
First Posted (Estimate)
August 20, 2012
Study Record Updates
Last Update Posted (Estimate)
August 20, 2012
Last Update Submitted That Met QC Criteria
August 16, 2012
Last Verified
August 1, 2012
More Information
Terms related to this study
Other Study ID Numbers
- TASMC-12-NG-0363-CTIL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Idiopathic Fallers
-
Tel-Aviv Sourasky Medical CenterUnknownElderly Idiopathic FallersUnited States, Israel
-
University of ÉvoraSão João de Deus School of Nursing; Horizon 2020 - Portugal 2020 (ALT20-03-0145-FEDER-000007...CompletedFallers | High Risk of FallingPortugal
-
Taipei Medical UniversityNational Health Research Institutes, TaiwanCompleted
-
Taipei Medical UniversityNational Health Research Institutes, TaiwanRecruitingMild Cognitive Impairment | FallersTaiwan
-
Assistance Publique - Hôpitaux de ParisCompletedHealthy | Fallers | Thalamic Pain SyndromeFrance
-
University Hospital, Clermont-FerrandCH RiomNot yet recruitingFallers Aged 60 Years and Older | Intracranial Bleeding | Biomarkers / BloodFrance
-
Lahore University of Biological and Applied SciencesGhurki Trust and Teaching HospitalNot yet recruitingScoliosis Idiopathic | Idiopathic Adolescent ScoliosisPakistan
-
Uppsala UniversityUniversity of Oslo; Linkoeping University; Örebro University, Sweden; Skane University... and other collaboratorsNot yet recruitingIdiopathic Adolescent Scoliosis | Idiopathic Juvenile ScoliosisSweden
-
National Scoliosis CenterCompletedAdolescent Idiopathic Scoliosis (AIS) | Neuromuscular Scoliosis | Juvenile Idiopathic Scoliosis | Infantile Idiopathic Scoliosis | Ealy Onset ScoliosisUnited States
-
Hasan Kalyoncu UniversityNot yet recruitingScoliosis Idiopathic | Scoliosis Idiopathic Adolescent | Caregiver AnxietyTurkey (Türkiye)
Clinical Trials on new system to detect Near Falls
-
RWTH Aachen UniversityB. Braun-StiftungNot yet recruitingDrug-Related Side Effects and Adverse Reactions | Pharmacogenetics | Polypharmacy | Pharmacogenomic Testing
-
University of Sao Paulo General HospitalCompleted
-
Mayo ClinicTerminatedEosinophilic EsophagitisUnited States
-
Ricardo Caio Gracco De BernardisHOSPITAL GERAL DE ITAPECERICA DA SERRAUnknownTemperature Change, BodyBrazil
-
JHP Pharmaceuticals LLCSyneos HealthUnknownTuberculosis Identification.
-
University of AarhusAarhus University Hospital; ADS AIPHIA Development Services AGTerminatedCirrhosis, Liver | Ascites HepaticDenmark
-
Alexandria UniversityCompleted
-
Braeburn PharmaceuticalsCompletedOpioid Use DisorderUnited States, United Kingdom, Taiwan, Hungary, Australia, Denmark, Germany, Sweden
-
Phramongkutklao College of Medicine and HospitalCompletedSevere Traumatic Brain Injury | Cerebral HypoxiaThailand
-
Johns Hopkins UniversityPhotocure ASARecruitingBladder CancerUnited States